The Caris Molecular Intelligence® comprehensive tumor profiling approach to assess DNA, RNA, and proteins reveals the highest quality molecular blueprint provide evidence-based selection of the most appropriate cancer therapy. Among our most cutting edge approaches is the utilization of artificial intelligence algorithms to make predictions of benefit from standard treatments, including chemotherapy. We are the original and most experienced comprehensive tumor profiling laboratory and have optimized our workflows to provide an industry-leading turnaround time of 10-14 days.
Unlike other tumor profiling services on the market, we use the best available technologies for biomarker identification. This approach allows our medical teams to more fully understand the biology of the tumor, which helps our oncologist colleagues plan their treatment strategy.
Caris Molecular Intelligence performs thorough molecular testing on DNA, RNA and proteins to identify the biomarkers driving a patient’s tumor, and to compare the biomarkers with data from clinical studies around the world. Here’s how the process works:
The ordering clinician collects and sends a tissue sample to Caris
Comprehensive testing on DNA, RNA and proteins is performed at our state-of-the-art, 66,000 sq. ft. laboratory
Team interprets the data using thousands of relevant clinical papers to match your tumor’s biomarkers to treatment options
Results are returned in approximately 10-14 days in an online and easy-to-understand format
Profiling reveals the molecular blueprint to help guide precise treatment decisions